Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer

Pegylated liposomal doxorubicin (PLD) is a nano-doxorubicin anticancer agent. It was used as early as 2014 to treat ovarian and breast cancer, multiple myeloma and Kaposi's sarcoma. The 2018 National Comprehensive Cancer Network guidelines listed PLD as first-line chemotherapy for ovarian cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin-Ru, Cheng, Xing-Han, Zhang, Guo-Nan, Wang, Xiao-Xin, Huang, Jian-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380363/
https://www.ncbi.nlm.nih.gov/pubmed/35971131
http://dx.doi.org/10.1186/s13048-022-01029-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380363/
https://www.ncbi.nlm.nih.gov/pubmed/35971131
http://dx.doi.org/10.1186/s13048-022-01029-6

Ejemplares similares